REGENXBIO INC (RGNX) Stock Cash Flow
NASDAQ:RGNX - Nasdaq - US75901B1070 - Common Stock - Currency: USD
| TTM (2024-9-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -238.81M | -263.49M | -280.30M | 127.80M | -111.30M | |||
| Depreciation Amortization | 16.51M | 17.32M | 12.90M | 9.60M | 8.40M | |||
| Change In Working Capital | 3.09M | -10.89M | 14.00M | 40.20M | 14.20M | |||
| Interest Paid | N/A | N/A | N/A | N/A | N/A | |||
| Taxes Paid | N/A | 142.00K | 11.80M | 6.00M | -200.00K | |||
| Other non cash items | 36.90M | 38.65M | 45.90M | 41.30M | 34.60M | |||
| OPERATING CASH FLOW | -182.31M | -218.41M | -207.50M | 218.90M | -54.10M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -2.52M | -9.96M | -30.70M | -84.20M | -26.90M | |||
| Other Investing Activity | 99.63M | 200.90M | 18.80M | -322.50M | 149.60M | |||
| INVESTING CASH FLOW | 97.12M | 190.94M | -11.90M | -406.60M | 122.80M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | N/A | N/A | N/A | N/A | N/A | |||
| Stock Issued/Repurchased | 133.02M | 7.80M | 4.30M | 222.50M | 7.40M | |||
| Other Financing Activity | -44.57M | -42.77M | -33.10M | -27.20M | 192.80M | |||
| FINANCING CASH FLOW | 88.46M | -34.97M | -28.80M | 195.30M | 200.20M | |||
| CHANGE IN CASH | 3.26M | -62.43M | -248.20M | 7.60M | 268.90M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -182.31M | -218.41M | -207.50M | 218.90M | -54.10M | |||
| Capital Expenditure | -2.52M | -9.96M | -30.70M | -84.20M | -26.90M | |||
| FREE CASH FLOW | -184.83M | -228.37M | -238.20M | 134.70M | -81.00M | |||
All data in USD